Bobin, Arthur
Kyheng, Maéva
Guidez, Stéphanie
Gruchet-Merouze, Cécile
Richez, Valentine
Duhamel, Alain
Karlin, Lionel
Kolb, Brigitte
Tiab, Mourad
Araujo, Carla
Meuleman, Nathalie
Malfuson, Jean-Valère
Bourquard, Pascal
Lenain, Pascal
Perrot, Aurore https://orcid.org/0000-0003-0131-8689
Roussel, Murielle https://orcid.org/0000-0002-4045-9428
Jaccard, Arnaud https://orcid.org/0000-0001-7091-8253
Petillon, Marie-Odile
Belhadj-Merzoug, Karim
Chretien, Marie-Lorraine
Fontan, Jean
Rodon, Philippe
Schmitt, Anna
Offner, Fritz
Voillat, Laurent
Cereja, Sophie
Kuhnowski, Frédérique
Rigaudeau, Sophie https://orcid.org/0000-0002-9639-9305
Decaux, Olivier
Humbrecht-Kraut, Catherine
Frayfer, Jamile
Fitoussi, Olivier
Roos-Weil, Damien
Eisenmann, Jean Claude
Dorvaux, Véronique
Voog, Eric G.
Moreau, Philippe
Avet-Loiseau, Hervé
Hulin, Cyrille
Facon, Thierry
,
Leleu, Xavier https://orcid.org/0000-0002-9822-4170
Article History
Received: 18 May 2021
Revised: 31 August 2021
Accepted: 6 September 2021
First Online: 14 October 2021
Competing interests
: XL honorarium from BMS Celgene, Janssen, Merck, Takeda, Amgen, Sanofi, Novartis, Roche, Karyopharm, Oncopeptide. LK honorarium from Janssen, Amgen, Celgene, advisory committees for Janssen, Amgen, Celgene, travel support from Janssen, Amgen. MR consultancy for Amgen, Celgene, Takeda. KBM consultancy and honorarium from Celgene, Janssen, Amgen, Takeda. OD honorarium from Celgene, Janssen, Takeda, Amgen. MA consultancy and research funding from Amgen, Celgene, Janssen, consultancy for Sanofi. PM honorarium and advisory committees for Amgen, Celgene, Janssen, Abbvie, Takeda, and speakers bureau for Amgen, Celgene, Janssen, Abbvie. HAL honorarium and advisory committees for Amgen, Celgene, Janssen, Sanofi, Abbvie, Takeda, research funding from Amgen, Celgene, Sanofi, Takeda. CH honorarium from Celgene, Janssen, Amgen, Takeda, research funding from Celgene, Janssen. TF honorarium and advisory committees and speakers bureau for Celgene, Janssen, Takeda, Amgen, Sanofi, Karyopharm, Oncopeptides.